AlphaGrep UK’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Sell
4,770
-3,071
-39% -$150K 0.08% 565
2026
Q1
$336K Sell
7,841
-7,045
-47% -$303K 0.1% 457
2025
Q4
$652K Buy
+14,886
New +$616K 0.22% 120

Other funds holding EXEL

AlphaGrep UK's EXEL Position: Q2 2026 in Review

AlphaGrep UK reduced its Exelixis (EXEL) stake by 39% in Q2 2026, selling an estimated $150K and leaving 4,770 shares worth $260K. The position accounts for 0.08% of the portfolio, ranked #565.

AlphaGrep UK first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. The position peaked at $652K in Q4 2025. 714 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • AlphaGrep UK held 4,770 shares of Exelixis worth $260K as of Q2 2026.
  • AlphaGrep UK sold 3,071 Exelixis shares in Q2 2026, an estimated $150K.
  • Exelixis made up 0.08% of AlphaGrep UK's portfolio in Q2 2026, its #565 holding.
  • AlphaGrep UK first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Exelixis position peaked at $652K in Q4 2025.
  • 714 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.